Status:
COMPLETED
Coagulation Changes Associated With COVID-19 Infection
Lead Sponsor:
HemoSonics LLC
Conditions:
COVID
Disseminated Intravascular Coagulation
Eligibility:
All Genders
18+ years
Brief Summary
This study will study the potential utility of the Quantra QPlus System in patients inflicted with COVID-19 disease.
Detailed Description
The Quantra System is a fully integrated and automated in vitro diagnostic device which uses SEER Sonorheometry, an ultrasound-based technology, to characterize the viscoelastic properties of a whole ...
Eligibility Criteria
Inclusion
- Subject is ≥ 18 years of age
- Subject has a diagnosis of COVID-19 and has been admitted to the hospital
- Subject has one or more risk factors for a poor outcome with COVID-10 disease: advanced age (\>=60 years), morbid obesity, diabetes, COPD, CAD
- Subject, or subject's legally authorized representative is willing and agrees to provide informed consent.
Exclusion
- Subject is younger than 18 years of age
- Subject is pregnant
- Subject is incarcerated.
- Subject, or subject's legally authorized representative is unable or unwilling to provide informed consent.
- Subject is affected by a condition that, in the opinion of the treatment team, may pose additional risks.
Key Trial Info
Start Date :
August 14 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 26 2022
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04460664
Start Date
August 14 2020
End Date
January 26 2022
Last Update
May 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Texas Tech University Health Sciences Center El Paso
El Paso, Texas, United States, 79905